共 531 条
[1]
Breuer GS(2020)Survival of patients with giant cell arteritis: a controversial issue Clin Exp Rheumatol 38 210-213
[2]
Poltorak V(2019)Overall survival and mortality risk factors in Takayasu’s arteritis: a multicenter study of 318 patients J Autoimmun 96 35-39
[3]
Nesher G(2019)Management of Takayasu arteritis: a systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis RMD Open 5 e001020-656
[4]
Mirouse A(2019)Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis: focus on giant cell arteritis RMD Open 5 e001003-827
[5]
Biard L(2016)Flares in biopsy-proven giant cell arteritis in northern Italy: characteristics and predictors in a long-term follow-up study Medicine (Baltimore) 95 e3524-1927
[6]
Comarmond C(2017)Incidence of outcomes potentially associated with corticosteroid therapy in patients with giant cell arteritis Semin Arthritis Rheum 46 650-30
[7]
Lambert M(2017)Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): A nested case-control analysis Semin Arthritis Rheum 46 819-e23
[8]
Mekinian A(2016)Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial Lancet 387 1921-165
[9]
Ferfar Y(2020)2018 Update of the EULAR recommendations for the management of large vessel vasculitis Ann Rheum Dis 79 19-265
[10]
Kahn JE(2020)British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis Rheumatology (Oxford) 59 e1-70